About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Society of Hematologic Oncology
Free SOHO Membership:
www.sohoonline.org
SOHO 2023
Leukemia
Lymphoma
Myeloma
MDS and MPN
Videos
SOHO 2022
Myeloma
Lymphoma
Leukemia
MDS and MPN
Benign Hematology
SOHO 2021
Myeloma
Cellular Therapy
Solid Tumors
Leukemia
MDS
Benign Hematology
MPN
Lymphoma
SOHO 2020
Basic Science
Lymphoma
Leukemia
Myeloma
MDS and MPN
Benign Hematology
SOHO Highlights: State of the Art and Next Questions
SOHO 2019
Hodgkin Lymphoma
Multiple Myeloma
Chronic Lymphocytic Leukemia
Meet The Professor Sessions
Chronic Myeloid Leukemia
Myeloproliferative Neoplasms
Breakfast With The Expert
Independent Satellite Symposium
Plenary Sessions
Evolving Practices in AML: A Case-based Guide to New and Emerging Treatment Options
Acute Lymphoblastic Leukemia
Myelodysplastic Syndromes
Acute Myeloid Leukemia
Indolent B-cell Lymphoma
Mantle Cell Lymphoma
Aggressive B-cell Lymphoma
T-cell Lymphoma
Cellular Therapy
Next Questions
SOHO 2018
Session I: Chronic Myeloid Leukemia
Session II: Myelodysplastic Syndromes
Session III: Myeloproliferative Neoplasms
Session IV: Acute Lymphoblastic Leukemia
Session V: Acute Myeloid Leukemia
Session VI: Multiple Myeloma
Session VIII: Non-Hodgkin Lymphoma
Session IX: Chronic Lymphocytic Leukemia
Session X: Research Topics
Plenary Sessions
Breakfast with the Expert
Events
Acute Myeloid Leukemia
15:38
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
2019 AML State of the Art Update: How to Treat Newly Diagnosed and Secondary AML, New AML Workup, Newer FLT3 Mutations, BCL-2 Inhibition, With Case Examples
FEATURING
Selina Luger
448 views
October 17, 2019
4
16:27
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
CAR T-Cells in AML: An Effective Therapy Requires Optimization of the CAR Design, Manufacturing Platform and Combinational Therapy
FEATURING
Elizabeth Budde
32 views
October 18, 2019
13:57
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Novel Strategies in High Risk AML: Clinical and Molecular Features
FEATURING
John Welch
19 views
October 17, 2019
16:06
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Chemotherapy-Free Approach in Relapsed/Refractory AML: Antibody-Drug Conjugates, Dual Affinity Re-Targeting (DART) and Bi-Specific T-Cell Engagers (BiTEs)
FEATURING
John DiPersio
313 views
October 18, 2019
1
15:39
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
All Older AML Patients and Younger Patients with Adverse Biology Should Receive HMA/Venetoclax Instead of 3+7/Standard Induction
FEATURING
Daniel Pollyea
1,014 views
October 17, 2019
8
17:20
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
HMA/Ventoclax vs. 3+7/Standard Induction - Should All Older and Younger AML Patients with Adverse Biology Routinely Receive It?
FEATURING
Jeffrey Lancet
41 views
October 18, 2019
15:19
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Use of MRD in AML: Determining Method, Acceptable Endpoint and Prognostic Significance in Younger/Intensively Treatment Patients and Older Less/Intensively Treated Patients
FEATURING
Pau Montesinos
19 views
October 18, 2019
14:52
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
How to Choose a FLT3 inhibitor in AML in 2019: Discussion on Midostaurin, Quizartinib, Crenolanib and Gilteritinib
FEATURING
Catherine Smith
41 views
October 18, 2019
15:52
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Use of Gemtuzumab in CD33 + AML: Benefit May Be Greatest in Favorable-Risk AML
FEATURING
Roland B. Walter
18 views
October 18, 2019
08:26
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Synergistic Activity of the MCL-1 Inhibitor S63845 with Midostaurin in Preclinical Human Models of FLT3- ITD Mutated AML - Inhibiton of Mcl-1 Improves Anti-Leukemia Efficacy
FEATURING
Anna Skwarska
21 views
October 18, 2019
09:44
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
The Promising Data on Efficacy of Mutant IDH1 Inhibitor Ivosidenib (IVO; AG-120) in Combination with Azacitidine (AZA) for Newly Diagnosed AML
FEATURING
Courtney D. DiNardo
26 views
October 18, 2019
08:59
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Genome-Wide CRISPR-Cas9 Screen Identifies XPO7 as a Novel Therapeutic Target for TP53-Mutated AML
FEATURING
Yuichiro Semba
10 views
October 18, 2019